| Autor: |
Tania Leme da Rocha Martinez, André Luis Valera Gasparoto, Ana Paula Pantoja Margeotto, Adenilton Rampinelli, Anita L R Saldanha, Eduardo Neris, Thomaz Braga Ceglias, Raoni Rego Godinho, Otávio Castilho |
| Rok vydání: |
2022 |
| Zdroj: |
International Journal of Family & Community Medicine. 6:56-57 |
| ISSN: |
2577-8269 |
| DOI: |
10.15406/ijfcm.2022.06.00264 |
| Popis: |
The COVID-19 pandemic has posed a big challenge to the healthcare community and many stakeholders. According to clinical studies, D-Dimer assays may be the "first line" of technical screening in symptomatic outpatients with suspected venous thrombosis or pulmonary embolism. This same affirmation may be applied to COVID-19 as its cause. In this study the comparison of the first two years of the COVID-19 appears the tendency of treatment decision making based in D-Dimer levels being a less important parameter. Many patients with COVID-19 have been observed to present with prominently elevated D-Dimers, findings which have been postulated to reflect underlying thromboembolic burden, which have been associated with increased mortality among such patients. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
